Your browser doesn't support javascript.
loading
Discovering a new drug is only the beginning: progress and challenges in expanding access to BDQ for MDR-TB treatment.
Cox, H; Shah, N S; Castro, K G.
Affiliation
  • Cox H; Institute of Infectious Disease and Molecular Medicine and Wellcome Centre for Infectious Disease Research, University of Cape Town, Cape Town, South Africa.
  • Shah NS; Rollins School of Public Health and School of Medicine, Emory University, Atlanta, GA.
  • Castro KG; Rollins School of Public Health and School of Medicine, Emory University, Atlanta, GA, Bureau for Global Health, US Agency for International Development, Washington, DC, USA, <email></email>, Email: helen.cox@uct.ac.za.
Int J Tuberc Lung Dis ; 24(10): 985-986, 2020 10 01.
Article in En | MEDLINE | ID: mdl-33126927
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Tuberculosis, Multidrug-Resistant Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2020 Document type: Article Affiliation country: Sudáfrica
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Tuberculosis, Multidrug-Resistant Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2020 Document type: Article Affiliation country: Sudáfrica